Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunome (IMNM) Amortizatization of Intangibles (2023 - 2025)

Historic Amortizatization of Intangibles for Immunome (IMNM) over the last 3 years, with Q3 2025 value amounting to $816000.0.

  • Immunome's Amortizatization of Intangibles fell 4460.29% to $816000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year increase of 523.85%. This contributed to the annual value of $2.9 million for FY2024, which is 46621.09% up from last year.
  • Immunome's Amortizatization of Intangibles amounted to $816000.0 in Q3 2025, which was down 4460.29% from $1.2 million recorded in Q2 2025.
  • Over the past 5 years, Immunome's Amortizatization of Intangibles peaked at $1.5 million during Q3 2024, and registered a low of -$442000.0 during Q3 2023.
  • Its 3-year average for Amortizatization of Intangibles is $568181.8, with a median of $538000.0 in 2024.
  • As far as peak fluctuations go, Immunome's Amortizatization of Intangibles skyrocketed by 89629.63% in 2024, and later crashed by 4460.29% in 2025.
  • Immunome's Amortizatization of Intangibles (Quarter) stood at $844000.0 in 2023, then plummeted by 36.49% to $536000.0 in 2024, then soared by 52.24% to $816000.0 in 2025.
  • Its Amortizatization of Intangibles was $816000.0 in Q3 2025, compared to $1.2 million in Q2 2025 and $818000.0 in Q1 2025.